- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biosimilars market size is estimated to be worth US$ 5893.3 million in 2021 and is forecast to a readjusted size of USD 17930 million by 2028 with a CAGR of 17.2% during review period. Oncology accounting for % of the Biosimilars global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biosimilars include Pfizer, Novartis, Biocon, Biogen, and Fresenius Kabi AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilars market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
Market segment by Application can be divided into
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
The key market players for global Biosimilars market are listed below:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars, with price, sales, revenue and global market share of Biosimilars from 2019 to 2022.
Chapter 3, the Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars.
Chapter 13, 14, and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilars Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilars Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Global Biosimilars Market Size & Forecast
1.4.1 Global Biosimilars Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biosimilars Sales in Volume (2017-2028)
1.4.3 Global Biosimilars Price (2017-2028)
1.5 Global Biosimilars Production Capacity Analysis
1.5.1 Global Biosimilars Total Production Capacity (2017-2028)
1.5.2 Global Biosimilars Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilars Market Drivers
1.6.2 Biosimilars Market Restraints
1.6.3 Biosimilars Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilars Product and Services
2.1.4 Pfizer Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Biosimilars Product and Services
2.2.4 Novartis Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Biosimilars Product and Services
2.3.4 Biocon Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business
2.4.3 Biogen Biosimilars Product and Services
2.4.4 Biogen Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Fresenius Kabi AG
2.5.1 Fresenius Kabi AG Details
2.5.2 Fresenius Kabi AG Major Business
2.5.3 Fresenius Kabi AG Biosimilars Product and Services
2.5.4 Fresenius Kabi AG Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Biosimilars Product and Services
2.6.4 Boehringer Ingelheim Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck KgaA
2.7.1 Merck KgaA Details
2.7.2 Merck KgaA Major Business
2.7.3 Merck KgaA Biosimilars Product and Services
2.7.4 Merck KgaA Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Biosimilars Product and Services
2.8.4 Mylan Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biosimilars Product and Services
2.9.4 Eli Lilly Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business
2.10.3 Teva Pharmaceutical Biosimilars Product and Services
2.10.4 Teva Pharmaceutical Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Dr. Reddy's Laboratories
2.11.1 Dr. Reddy's Laboratories Details
2.11.2 Dr. Reddy's Laboratories Major Business
2.11.3 Dr. Reddy's Laboratories Biosimilars Product and Services
2.11.4 Dr. Reddy's Laboratories Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Amgen
2.12.1 Amgen Details
2.12.2 Amgen Major Business
2.12.3 Amgen Biosimilars Product and Services
2.12.4 Amgen Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Celltrion
2.13.1 Celltrion Details
2.13.2 Celltrion Major Business
2.13.3 Celltrion Biosimilars Product and Services
2.13.4 Celltrion Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Samsung Biologics
2.14.1 Samsung Biologics Details
2.14.2 Samsung Biologics Major Business
2.14.3 Samsung Biologics Biosimilars Product and Services
2.14.4 Samsung Biologics Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Biosimilars Product and Services
2.15.4 Roche Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Probiomed
2.16.1 Probiomed Details
2.16.2 Probiomed Major Business
2.16.3 Probiomed Biosimilars Product and Services
2.16.4 Probiomed Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business
2.17.3 Apotex Biosimilars Product and Services
2.17.4 Apotex Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Chong Kun Dang
2.18.1 Chong Kun Dang Details
2.18.2 Chong Kun Dang Major Business
2.18.3 Chong Kun Dang Biosimilars Product and Services
2.18.4 Chong Kun Dang Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 JCR Pharmaceuticals
2.19.1 JCR Pharmaceuticals Details
2.19.2 JCR Pharmaceuticals Major Business
2.19.3 JCR Pharmaceuticals Biosimilars Product and Services
2.19.4 JCR Pharmaceuticals Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Gan & Lee Pharmaceuticals
2.20.1 Gan & Lee Pharmaceuticals Details
2.20.2 Gan & Lee Pharmaceuticals Major Business
2.20.3 Gan & Lee Pharmaceuticals Biosimilars Product and Services
2.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Gedeon Richter
2.21.1 Gedeon Richter Details
2.21.2 Gedeon Richter Major Business
2.21.3 Gedeon Richter Biosimilars Product and Services
2.21.4 Gedeon Richter Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Biocad
2.22.1 Biocad Details
2.22.2 Biocad Major Business
2.22.3 Biocad Biosimilars Product and Services
2.22.4 Biocad Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Coherus Bioscience
2.23.1 Coherus Bioscience Details
2.23.2 Coherus Bioscience Major Business
2.23.3 Coherus Bioscience Biosimilars Product and Services
2.23.4 Coherus Bioscience Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Stada Arzneimittel AG
2.24.1 Stada Arzneimittel AG Details
2.24.2 Stada Arzneimittel AG Major Business
2.24.3 Stada Arzneimittel AG Biosimilars Product and Services
2.24.4 Stada Arzneimittel AG Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biosimilars Breakdown Data by Manufacturer
3.1 Global Biosimilars Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biosimilars
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilars Manufacturer Market Share in 2021
3.4.2 Top 6 Biosimilars Manufacturer Market Share in 2021
3.5 Global Biosimilars Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biosimilars Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilars Market Size by Region
4.1.1 Global Biosimilars Sales in Volume by Region (2017-2028)
4.1.2 Global Biosimilars Revenue by Region (2017-2028)
4.2 North America Biosimilars Revenue (2017-2028)
4.3 Europe Biosimilars Revenue (2017-2028)
4.4 Asia-Pacific Biosimilars Revenue (2017-2028)
4.5 South America Biosimilars Revenue (2017-2028)
4.6 Middle East and Africa Biosimilars Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biosimilars Sales in Volume by Type (2017-2028)
5.2 Global Biosimilars Revenue by Type (2017-2028)
5.3 Global Biosimilars Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biosimilars Sales in Volume by Application (2017-2028)
6.2 Global Biosimilars Revenue by Application (2017-2028)
6.3 Global Biosimilars Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilars Sales by Type (2017-2028)
7.2 North America Biosimilars Sales by Application (2017-2028)
7.3 North America Biosimilars Market Size by Country
7.3.1 North America Biosimilars Sales in Volume by Country (2017-2028)
7.3.2 North America Biosimilars Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilars Sales by Type (2017-2028)
8.2 Europe Biosimilars Sales by Application (2017-2028)
8.3 Europe Biosimilars Market Size by Country
8.3.1 Europe Biosimilars Sales in Volume by Country (2017-2028)
8.3.2 Europe Biosimilars Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biosimilars Sales by Type (2017-2028)
9.2 Asia-Pacific Biosimilars Sales by Application (2017-2028)
9.3 Asia-Pacific Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biosimilars Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biosimilars Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biosimilars Sales by Type (2017-2028)
10.2 South America Biosimilars Sales by Application (2017-2028)
10.3 South America Biosimilars Market Size by Country
10.3.1 South America Biosimilars Sales in Volume by Country (2017-2028)
10.3.2 South America Biosimilars Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilars Sales by Type (2017-2028)
11.2 Middle East & Africa Biosimilars Sales by Application (2017-2028)
11.3 Middle East & Africa Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biosimilars Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biosimilars Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biosimilars and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biosimilars
12.3 Biosimilars Production Process
12.4 Biosimilars Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biosimilars Typical Distributors
13.3 Biosimilars Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biosimilars Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biosimilars Product and Services
Table 6. Pfizer Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Biosimilars Product and Services
Table 10. Novartis Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biocon Basic Information, Manufacturing Base and Competitors
Table 12. Biocon Major Business
Table 13. Biocon Biosimilars Product and Services
Table 14. Biocon Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biogen Basic Information, Manufacturing Base and Competitors
Table 16. Biogen Major Business
Table 17. Biogen Biosimilars Product and Services
Table 18. Biogen Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi AG Major Business
Table 21. Fresenius Kabi AG Biosimilars Product and Services
Table 22. Fresenius Kabi AG Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Major Business
Table 25. Boehringer Ingelheim Biosimilars Product and Services
Table 26. Boehringer Ingelheim Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck KgaA Basic Information, Manufacturing Base and Competitors
Table 28. Merck KgaA Major Business
Table 29. Merck KgaA Biosimilars Product and Services
Table 30. Merck KgaA Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Biosimilars Product and Services
Table 34. Mylan Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Biosimilars Product and Services
Table 38. Eli Lilly Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Major Business
Table 41. Teva Pharmaceutical Biosimilars Product and Services
Table 42. Teva Pharmaceutical Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Dr. Reddy's Laboratories Major Business
Table 45. Dr. Reddy's Laboratories Biosimilars Product and Services
Table 46. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Amgen Basic Information, Manufacturing Base and Competitors
Table 48. Amgen Major Business
Table 49. Amgen Biosimilars Product and Services
Table 50. Amgen Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Celltrion Basic Information, Manufacturing Base and Competitors
Table 52. Celltrion Major Business
Table 53. Celltrion Biosimilars Product and Services
Table 54. Celltrion Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 56. Samsung Biologics Major Business
Table 57. Samsung Biologics Biosimilars Product and Services
Table 58. Samsung Biologics Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Roche Basic Information, Manufacturing Base and Competitors
Table 60. Roche Major Business
Table 61. Roche Biosimilars Product and Services
Table 62. Roche Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Probiomed Basic Information, Manufacturing Base and Competitors
Table 64. Probiomed Major Business
Table 65. Probiomed Biosimilars Product and Services
Table 66. Probiomed Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Apotex Basic Information, Manufacturing Base and Competitors
Table 68. Apotex Major Business
Table 69. Apotex Biosimilars Product and Services
Table 70. Apotex Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Chong Kun Dang Basic Information, Manufacturing Base and Competitors
Table 72. Chong Kun Dang Major Business
Table 73. Chong Kun Dang Biosimilars Product and Services
Table 74. Chong Kun Dang Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. JCR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. JCR Pharmaceuticals Major Business
Table 77. JCR Pharmaceuticals Biosimilars Product and Services
Table 78. JCR Pharmaceuticals Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Gan & Lee Pharmaceuticals Major Business
Table 81. Gan & Lee Pharmaceuticals Biosimilars Product and Services
Table 82. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 84. Gedeon Richter Major Business
Table 85. Gedeon Richter Biosimilars Product and Services
Table 86. Gedeon Richter Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Biocad Basic Information, Manufacturing Base and Competitors
Table 88. Biocad Major Business
Table 89. Biocad Biosimilars Product and Services
Table 90. Biocad Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Coherus Bioscience Basic Information, Manufacturing Base and Competitors
Table 92. Coherus Bioscience Major Business
Table 93. Coherus Bioscience Biosimilars Product and Services
Table 94. Coherus Bioscience Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 96. Stada Arzneimittel AG Major Business
Table 97. Stada Arzneimittel AG Biosimilars Product and Services
Table 98. Stada Arzneimittel AG Biosimilars Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Global Biosimilars Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 100. Global Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 101. Market Position of Manufacturers in Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 102. Global Biosimilars Production Capacity by Company, (K MT): 2020 VS 2021
Table 103. Head Office and Biosimilars Production Site of Key Manufacturer
Table 104. Biosimilars New Entrant and Capacity Expansion Plans
Table 105. Biosimilars Mergers & Acquisitions in the Past Five Years
Table 106. Global Biosimilars Sales by Region (2017-2022) & (K MT)
Table 107. Global Biosimilars Sales by Region (2023-2028) & (K MT)
Table 108. Global Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 109. Global Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 110. Global Biosimilars Sales by Type (2017-2022) & (K MT)
Table 111. Global Biosimilars Sales by Type (2023-2028) & (K MT)
Table 112. Global Biosimilars Revenue by Type (2017-2022) & (USD Million)
Table 113. Global Biosimilars Revenue by Type (2023-2028) & (USD Million)
Table 114. Global Biosimilars Price by Type (2017-2022) & (USD/MT)
Table 115. Global Biosimilars Price by Type (2023-2028) & (USD/MT)
Table 116. Global Biosimilars Sales by Application (2017-2022) & (K MT)
Table 117. Global Biosimilars Sales by Application (2023-2028) & (K MT)
Table 118. Global Biosimilars Revenue by Application (2017-2022) & (USD Million)
Table 119. Global Biosimilars Revenue by Application (2023-2028) & (USD Million)
Table 120. Global Biosimilars Price by Application (2017-2022) & (USD/MT)
Table 121. Global Biosimilars Price by Application (2023-2028) & (USD/MT)
Table 122. North America Biosimilars Sales by Country (2017-2022) & (K MT)
Table 123. North America Biosimilars Sales by Country (2023-2028) & (K MT)
Table 124. North America Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 125. North America Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 126. North America Biosimilars Sales by Type (2017-2022) & (K MT)
Table 127. North America Biosimilars Sales by Type (2023-2028) & (K MT)
Table 128. North America Biosimilars Sales by Application (2017-2022) & (K MT)
Table 129. North America Biosimilars Sales by Application (2023-2028) & (K MT)
Table 130. Europe Biosimilars Sales by Country (2017-2022) & (K MT)
Table 131. Europe Biosimilars Sales by Country (2023-2028) & (K MT)
Table 132. Europe Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 133. Europe Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 134. Europe Biosimilars Sales by Type (2017-2022) & (K MT)
Table 135. Europe Biosimilars Sales by Type (2023-2028) & (K MT)
Table 136. Europe Biosimilars Sales by Application (2017-2022) & (K MT)
Table 137. Europe Biosimilars Sales by Application (2023-2028) & (K MT)
Table 138. Asia-Pacific Biosimilars Sales by Region (2017-2022) & (K MT)
Table 139. Asia-Pacific Biosimilars Sales by Region (2023-2028) & (K MT)
Table 140. Asia-Pacific Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 142. Asia-Pacific Biosimilars Sales by Type (2017-2022) & (K MT)
Table 143. Asia-Pacific Biosimilars Sales by Type (2023-2028) & (K MT)
Table 144. Asia-Pacific Biosimilars Sales by Application (2017-2022) & (K MT)
Table 145. Asia-Pacific Biosimilars Sales by Application (2023-2028) & (K MT)
Table 146. South America Biosimilars Sales by Country (2017-2022) & (K MT)
Table 147. South America Biosimilars Sales by Country (2023-2028) & (K MT)
Table 148. South America Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 149. South America Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 150. South America Biosimilars Sales by Type (2017-2022) & (K MT)
Table 151. South America Biosimilars Sales by Type (2023-2028) & (K MT)
Table 152. South America Biosimilars Sales by Application (2017-2022) & (K MT)
Table 153. South America Biosimilars Sales by Application (2023-2028) & (K MT)
Table 154. Middle East & Africa Biosimilars Sales by Region (2017-2022) & (K MT)
Table 155. Middle East & Africa Biosimilars Sales by Region (2023-2028) & (K MT)
Table 156. Middle East & Africa Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 157. Middle East & Africa Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 158. Middle East & Africa Biosimilars Sales by Type (2017-2022) & (K MT)
Table 159. Middle East & Africa Biosimilars Sales by Type (2023-2028) & (K MT)
Table 160. Middle East & Africa Biosimilars Sales by Application (2017-2022) & (K MT)
Table 161. Middle East & Africa Biosimilars Sales by Application (2023-2028) & (K MT)
Table 162. Biosimilars Raw Material
Table 163. Key Manufacturers of Biosimilars Raw Materials
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. Biosimilars Typical Distributors
Table 167. Biosimilars Typical Customers
List of Figures
Figure 1. Biosimilars Picture
Figure 2. Global Biosimilars Revenue Market Share by Type in 2021
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure 4. Recombinant Glycosylated Proteins
Figure 5. Global Biosimilars Revenue Market Share by Application in 2021
Figure 6. Oncology
Figure 7. Blood Disorders
Figure 8. Growth Hormonal Deficiency
Figure 9. Chronic and Autoimmune Disorders
Figure 10. Others
Figure 11. Global Biosimilars Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Biosimilars Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biosimilars Sales (2017-2028) & (K MT)
Figure 14. Global Biosimilars Price (2017-2028) & (USD/MT)
Figure 15. Global Biosimilars Production Capacity (2017-2028) & (K MT)
Figure 16. Global Biosimilars Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Biosimilars Market Drivers
Figure 18. Biosimilars Market Restraints
Figure 19. Biosimilars Market Trends
Figure 20. Global Biosimilars Sales Market Share by Manufacturer in 2021
Figure 21. Global Biosimilars Revenue Market Share by Manufacturer in 2021
Figure 22. Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Biosimilars Sales Market Share by Region (2017-2028)
Figure 26. Global Biosimilars Revenue Market Share by Region (2017-2028)
Figure 27. North America Biosimilars Revenue (2017-2028) & (USD Million)
Figure 28. Europe Biosimilars Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Biosimilars Revenue (2017-2028) & (USD Million)
Figure 30. South America Biosimilars Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Biosimilars Revenue (2017-2028) & (USD Million)
Figure 32. Global Biosimilars Sales Market Share by Type (2017-2028)
Figure 33. Global Biosimilars Revenue Market Share by Type (2017-2028)
Figure 34. Global Biosimilars Price by Type (2017-2028) & (USD/MT)
Figure 35. Global Biosimilars Sales Market Share by Application (2017-2028)
Figure 36. Global Biosimilars Revenue Market Share by Application (2017-2028)
Figure 37. Global Biosimilars Price by Application (2017-2028) & (USD/MT)
Figure 38. North America Biosimilars Sales Market Share by Type (2017-2028)
Figure 39. North America Biosimilars Sales Market Share by Application (2017-2028)
Figure 40. North America Biosimilars Sales Market Share by Country (2017-2028)
Figure 41. North America Biosimilars Revenue Market Share by Country (2017-2028)
Figure 42. United States Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Biosimilars Sales Market Share by Type (2017-2028)
Figure 46. Europe Biosimilars Sales Market Share by Application (2017-2028)
Figure 47. Europe Biosimilars Sales Market Share by Country (2017-2028)
Figure 48. Europe Biosimilars Revenue Market Share by Country (2017-2028)
Figure 49. Germany Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Biosimilars Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Biosimilars Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Biosimilars Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Biosimilars Revenue Market Share by Region (2017-2028)
Figure 58. China Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Biosimilars Sales Market Share by Type (2017-2028)
Figure 65. South America Biosimilars Sales Market Share by Application (2017-2028)
Figure 66. South America Biosimilars Sales Market Share by Country (2017-2028)
Figure 67. South America Biosimilars Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Biosimilars Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Biosimilars Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Biosimilars Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Biosimilars Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Biosimilars in 2021
Figure 79. Manufacturing Process Analysis of Biosimilars
Figure 80. Biosimilars Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
